Dimensional Fund Advisors’s Enfusion, Inc. ENFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-809,336
Closed -$9.02M 3352
2025
Q1
$9.02M Buy
809,336
+10,466
+1% +$116K ﹤0.01% 2293
2024
Q4
$8.23M Buy
798,870
+110,364
+16% +$1.07M ﹤0.01% 2375
2024
Q3
$6.53M Buy
688,506
+164,364
+31% +$1.42M ﹤0.01% 2439
2024
Q2
$4.47M Buy
524,142
+191,436
+58% +$1.75M ﹤0.01% 2525
2024
Q1
$3.08M Buy
332,706
+151,362
+83% +$1.33M ﹤0.01% 2679
2023
Q4
$1.76M Buy
181,344
+88,667
+96% +$828K ﹤0.01% 2812
2023
Q3
$831K Buy
92,677
+62,386
+206% +$592K ﹤0.01% 2960
2023
Q2
$340K Buy
+30,291
New +$269K ﹤0.01% 3137

Other funds holding ENFN

Dimensional Fund Advisors's ENFN Position: Q2 2025 in Review

Dimensional Fund Advisors sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 809,336 shares — an estimated $9.02M sold.

Dimensional Fund Advisors first reported a position in ENFN in Q2 2023 and held it in 8 quarters. The position peaked at $9.02M in Q1 2025. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

  • Dimensional Fund Advisors reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
  • Dimensional Fund Advisors sold 809,336 Enfusion, Inc. shares in Q2 2025, an estimated $9.02M.
  • Dimensional Fund Advisors first reported a position in Enfusion, Inc. in Q2 2023 and held it in 8 quarters.
  • Dimensional Fund Advisors's Enfusion, Inc. position peaked at $9.02M in Q1 2025.
  • 2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Dimensional Fund Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.